These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23614849)

  • 1. Physician-pharmacist co-management and 24-hour blood pressure control.
    Chen Z; Ernst ME; Ardery G; Xu Y; Carter BL
    J Clin Hypertens (Greenwich); 2013 May; 15(5):337-43. PubMed ID: 23614849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures.
    Weber CA; Ernst ME; Sezate GS; Zheng S; Carter BL
    Arch Intern Med; 2010 Oct; 170(18):1634-9. PubMed ID: 20937921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial.
    Hirsch JD; Steers N; Adler DS; Kuo GM; Morello CM; Lang M; Singh RF; Wood Y; Kaplan RM; Mangione CM
    Clin Ther; 2014 Sep; 36(9):1244-54. PubMed ID: 25085406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician and pharmacist collaboration to improve blood pressure control.
    Carter BL; Ardery G; Dawson JD; James PA; Bergus GR; Doucette WR; Chrischilles EA; Franciscus CL; Xu Y
    Arch Intern Med; 2009 Nov; 169(21):1996-2002. PubMed ID: 19933962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of a multidisciplinary information technology-supported program on blood pressure control in primary care.
    Rinfret S; Lussier MT; Peirce A; Duhamel F; Cossette S; Lalonde L; Tremblay C; Guertin MC; LeLorier J; Turgeon J; Hamet P;
    Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):170-7. PubMed ID: 20031834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Outcomes of the Effects of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Among Adults With Uncontrolled Hypertension: Follow-up of a Cluster Randomized Clinical Trial.
    Margolis KL; Asche SE; Dehmer SP; Bergdall AR; Green BB; Sperl-Hillen JM; Nyboer RA; Pawloski PA; Maciosek MV; Trower NK; O'Connor PJ
    JAMA Netw Open; 2018 Sep; 1(5):e181617. PubMed ID: 30646139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key components of success in a randomized trial of blood pressure telemonitoring with medication therapy management pharmacists.
    Beran M; Asche SE; Bergdall AR; Crabtree B; Green BB; Groen SE; Klotzle KJ; Michels RD; Nyboer RA; O'Connor PJ; Pawloski PA; Rehrauer DJ; Sperl-Hillen JM; Trower NK; Margolis KL
    J Am Pharm Assoc (2003); 2018; 58(6):614-621. PubMed ID: 30077564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist-Directed Self-Management of Blood Pressure Versus Conventional Management in Patients with Hypertension: A Randomized Control Trial.
    Khiali S; Khezerlo-Aghdam N; Namdar H; Entezari-Maleki T
    High Blood Press Cardiovasc Prev; 2021 May; 28(3):283-290. PubMed ID: 33765257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thresholds for Ambulatory Blood Pressure Among African Americans in the Jackson Heart Study.
    Ravenell J; Shimbo D; Booth JN; Sarpong DF; Agyemang C; Beatty Moody DL; Abdalla M; Spruill TM; Shallcross AJ; Bress AP; Muntner P; Ogedegbe G
    Circulation; 2017 Jun; 135(25):2470-2480. PubMed ID: 28428231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician-pharmacist comanagement of hypertension: a randomized, comparative trial.
    Borenstein JE; Graber G; Saltiel E; Wallace J; Ryu S; Archi J; Deutsch S; Weingarten SR
    Pharmacotherapy; 2003 Feb; 23(2):209-16. PubMed ID: 12587810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained blood pressure control following discontinuation of a pharmacist intervention.
    Wentzlaff DM; Carter BL; Ardery G; Franciscus CL; Doucette WR; Chrischilles EA; Rosenkrans KA; Buys LM
    J Clin Hypertens (Greenwich); 2011 Jun; 13(6):431-7. PubMed ID: 21649843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multimodal blood pressure control intervention in 3 healthcare systems.
    Magid DJ; Ho PM; Olson KL; Brand DW; Welch LK; Snow KE; Lambert-Kerzner AC; Plomondon ME; Havranek EP
    Am J Manag Care; 2011 Apr; 17(4):e96-103. PubMed ID: 21774100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial.
    Margolis KL; Asche SE; Bergdall AR; Dehmer SP; Groen SE; Kadrmas HM; Kerby TJ; Klotzle KJ; Maciosek MV; Michels RD; O'Connor PJ; Pritchard RA; Sekenski JL; Sperl-Hillen JM; Trower NK
    JAMA; 2013 Jul; 310(1):46-56. PubMed ID: 23821088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Description of pharmacist interventions during physician-pharmacist co-management of hypertension.
    Von Muenster SJ; Carter BL; Weber CA; Ernst ME; Milchak JL; Steffensmeier JJ; Xu Y
    Pharm World Sci; 2008 Jan; 30(1):128-35. PubMed ID: 17710561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative intervention.
    Carter BL; Doucette WR; Franciscus CL; Ardery G; Kluesner KM; Chrischilles EA
    Pharmacotherapy; 2010 Mar; 30(3):228-35. PubMed ID: 20180606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial.
    Heisler M; Hofer TP; Schmittdiel JA; Selby JV; Klamerus ML; Bosworth HB; Bermann M; Kerr EA
    Circulation; 2012 Jun; 125(23):2863-72. PubMed ID: 22570370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical Trial.
    Kandzari DE; Weber MA; Pathak A; Zidar JP; Saxena M; David SW; Schmieder RE; Janas AJ; Langer C; Persu A; Mendelsohn FO; Ameloot K; Foster M; Fischell TA; Parise H; Mahfoud F
    Circulation; 2024 Jun; 149(24):1875-1884. PubMed ID: 38587557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial to assess pharmacist- physician collaborative practice in the management of metabolic syndrome in a university medical clinic in Jordan.
    Hammad EA; Yasein N; Tahaineh L; Albsoul-Younes AM
    J Manag Care Pharm; 2011 May; 17(4):295-303. PubMed ID: 21534640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.